Conference call regarding Elekta's Interim Report for May-July 2016/17

STOCKHOLM, August 17 – Elekta (EKTA-B.ST) will publish its Interim Report for May-July 2016/17 on September 1, as per:

  • The report will be published at 07:30 CET
  • Elekta will host a telephone conference starting at 10:00 CET with Richard Hausmann, President and CEO and Håkan Bergström, CFO

To take part in the conference call, please dial in about five minutes in advance.

  • UK dial-in number: +44 (0) 203 428 1402
  • US dial-in number: +1 866 388 1925
  • Swedish dial-in number: +46 (0) 8 566 427 01 

The telephone conference will also be broadcasted live online, through the following link (however, in order to ask questions it is necessary to call in):  

# # #

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website:

Press Releases


PDF Version

For further information, please contact

Johan Andersson, Director Investor Relations, Elekta AB.
Tel: +46 702 100 451,
Time zone: CET: Central European Time

Tobias Bülow, Director Financial Communication, Elekta AB
Tel: +46 722 215 017,
Time zone: CET: Central European Time

Frida Johansson, Investor Relations, Elekta AB
Tel: +46 708 667 674,
Time zone: CET: Central European Time